Artigo - Atena Editora

Artigo

Baixe agora

Livros

GLAUCOMA IN POSNER-SCHLOSSMAN SYNDROME: A LITERATURE REVIEW

INTRODUCTION: Posner-Schlossman Syndrome is a unilateral inflammatory disease described in 1948 with great importance in the differential diagnosis of Glaucoma in adults. METHODOLOGY: Data collection research from articles and clinical trials was randomized on the PubMed platform, using the descriptors “glaucoma” and “Posner-Schlossman syndrome”. DISCUSSION: This condition is predominantly unilateral and affects young adults with recurrent episodes of chamber inflammation. anterior without formation of synechiae, with mild ocular discomfort and occasional reduction in visual acuity. Treatment ranges from the use of corticosteroids and topical cycloplegics to filtering surgeries. Cytomegalovirus has recently been implicated as a protagonist in the development of the condition, with studies promising results demonstrating the reduction of intraocular pressure with the use of antivirals.

Ler mais

GLAUCOMA IN POSNER-SCHLOSSMAN SYNDROME: A LITERATURE REVIEW

  • DOI: 10.22533/at.ed.1593922308113

  • Palavras-chave: Posner-Schlossman Syndrome, Glaucoma.

  • Keywords: Posner-Schlossman Syndrome, Glaucoma.

  • Abstract:

    INTRODUCTION: Posner-Schlossman Syndrome is a unilateral inflammatory disease described in 1948 with great importance in the differential diagnosis of Glaucoma in adults. METHODOLOGY: Data collection research from articles and clinical trials was randomized on the PubMed platform, using the descriptors “glaucoma” and “Posner-Schlossman syndrome”. DISCUSSION: This condition is predominantly unilateral and affects young adults with recurrent episodes of chamber inflammation. anterior without formation of synechiae, with mild ocular discomfort and occasional reduction in visual acuity. Treatment ranges from the use of corticosteroids and topical cycloplegics to filtering surgeries. Cytomegalovirus has recently been implicated as a protagonist in the development of the condition, with studies promising results demonstrating the reduction of intraocular pressure with the use of antivirals.

  • Silvio Tibo Cardoso Filho
  • Luan Mendes de Matos
Fale conosco Whatsapp